{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:41:12Z","timestamp":1787002872783,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:00:00Z","timestamp":1623888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:00:00Z","timestamp":1623888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1147319N"],"award-info":[{"award-number":["1147319N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Emmanuel van der Schueren fellowship from Kom Op Tegen Kanker"},{"DOI":"10.13039\/501100005026","name":"Stichting Tegen Kanker","doi-asserted-by":"publisher","award":["fellowship"],"award-info":[{"award-number":["fellowship"]}],"id":[{"id":"10.13039\/501100005026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005026","name":"Stichting Tegen Kanker","doi-asserted-by":"publisher","award":["2018\/1272"],"award-info":[{"award-number":["2018\/1272"]}],"id":[{"id":"10.13039\/501100005026","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fonds Tom Debackere voor Lymfoomonderzoek"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of non-Hodgkin lymphomas with poor prognosis. Up to 30% of PTCL lack distinctive features and are classified as PTCL, not otherwise specified (PTCL-NOS). To further improve our understanding of the genetic landscape and biology of PTCL-NOS, we perform RNA-sequencing of 18 cases and validate results in an independent cohort of 37 PTCL cases. We identify\n                    <jats:italic>FYN-TRAF3IP2<\/jats:italic>\n                    ,\n                    <jats:italic>KHDRBS1-LCK<\/jats:italic>\n                    and\n                    <jats:italic>SIN3A-FOXO1<\/jats:italic>\n                    as new in-frame fusion transcripts, with\n                    <jats:italic>FYN-TRAF3IP2<\/jats:italic>\n                    as a recurrent fusion detected in 8 of 55 cases. Using ex vivo and in vivo experiments, we demonstrate that\n                    <jats:italic>FYN-TRAF3IP2<\/jats:italic>\n                    and\n                    <jats:italic>KHDRBS1-LCK<\/jats:italic>\n                    activate signaling pathways downstream of the T cell receptor (TCR) complex and confer therapeutic vulnerability to clinically available drugs.\n                  <\/jats:p>","DOI":"10.1038\/s41467-021-24037-4","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T06:03:09Z","timestamp":1623909789000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified"],"prefix":"10.1038","volume":"12","author":[{"given":"Koen","family":"Debackere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Marcelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"Demeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0111-0263","authenticated-orcid":false,"given":"Marlies","family":"Vanden Bempt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Mentens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3813-750X","authenticated-orcid":false,"given":"Olga","family":"Gielen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Broux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Verhoef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucienne","family":"Michaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Graux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Wlodarska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gaulard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3994-516X","authenticated-orcid":false,"given":"Laurence","family":"de Leval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Tousseyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6626-5843","authenticated-orcid":false,"given":"Jan","family":"Cools","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8917-022X","authenticated-orcid":false,"given":"Daan","family":"Dierickx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,17]]},"reference":[{"key":"24037_CR1","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","volume":"124","author":"ER Parrilla Castellar","year":"2014","unstructured":"Parrilla Castellar, E. R. et al. ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes. Blood 124, 1473\u20131480 (2014).","journal-title":"Blood"},{"key":"24037_CR2","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose, J., Armitage, J. & Weisenburger, D. International T-Cell Lymphoma Project International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J. Clin. Oncol. 26, 4124\u20134130 (2008).","journal-title":"J. Clin. Oncol."},{"key":"24037_CR3","doi-asserted-by":"publisher","first-page":"v108","DOI":"10.1093\/annonc\/mdv201","volume":"26","author":"F d\u2019Amore","year":"2015","unstructured":"d\u2019Amore, F. et al. Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 26, v108\u2013v115 (2015).","journal-title":"Ann. Oncol."},{"key":"24037_CR4","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1182\/blood-2018-09-872549","volume":"133","author":"TB Heavican","year":"2019","unstructured":"Heavican, T. B. et al. Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma. Blood 133, 1664\u20131676 (2019).","journal-title":"Blood"},{"key":"24037_CR5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41379-019-0279-8","volume":"33","author":"MA Laginestra","year":"2020","unstructured":"Laginestra, M. A. et al. Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified. Mod. Pathol. 33, 179\u2013187 (2020).","journal-title":"Mod. Pathol."},{"key":"24037_CR6","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1038\/s41375-019-0473-1","volume":"33","author":"Y Watatani","year":"2019","unstructured":"Watatani, Y. et al. Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling. Leukemia 33, 2867\u20132883 (2019).","journal-title":"Leukemia"},{"key":"24037_CR7","doi-asserted-by":"publisher","first-page":"5655","DOI":"10.1038\/onc.2013.565","volume":"33","author":"D Nagel","year":"2014","unstructured":"Nagel, D., Vincendeau, M., Eitelhuber, A. C. & Krappmann, D. Mechanisms and consequences of constitutive NF-kappaB activation in B-cell lymphoid malignancies. Oncogene 33, 5655\u20135665 (2014).","journal-title":"Oncogene"},{"key":"24037_CR8","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1084\/jem.20092042","volume":"207","author":"K Pechloff","year":"2010","unstructured":"Pechloff, K. et al. The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma. J. Exp. Med 207, 1031\u20131044 (2010).","journal-title":"J. Exp. Med"},{"key":"24037_CR9","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.molcel.2015.07.025","volume":"59","author":"J An","year":"2015","unstructured":"An, J. et al. Truncated ERG oncoproteins from TMPRSS2-ERG fusions are resistant to SPOP-mediated proteasome degradation. Mol. Cell 59, 904\u2013916 (2015).","journal-title":"Mol. Cell"},{"key":"24037_CR10","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nrc3947","volume":"15","author":"F Mertens","year":"2015","unstructured":"Mertens, F., Johansson, B., Fioretos, T. & Mitelman, F. The emerging complexity of gene fusions in cancer. Nat. Rev. Cancer 15, 371\u2013381 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"24037_CR11","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1073\/pnas.1608839114","volume":"114","author":"F Abate","year":"2017","unstructured":"Abate, F. et al. Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas. Proc. Natl Acad. Sci. USA 114, 764\u2013769 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"24037_CR12","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","volume":"27","author":"R Crescenzo","year":"2015","unstructured":"Crescenzo, R. et al. Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma. Cancer Cell 27, 516\u2013532 (2015).","journal-title":"Cancer Cell"},{"key":"24037_CR13","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1182\/blood.2019002401","volume":"135","author":"K Debackere","year":"2020","unstructured":"Debackere, K. et al. FER and FES tyrosine kinase fusions in follicular T-cell lymphoma. Blood 135, 584\u2013588 (2020).","journal-title":"Blood"},{"key":"24037_CR14","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1182\/blood.V90.8.2901","volume":"90","author":"MU Kuefer","year":"1997","unstructured":"Kuefer, M. U. et al. Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice. Blood 90, 2901\u20132910 (1997).","journal-title":"Blood"},{"key":"24037_CR15","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1182\/blood-2012-01-405555","volume":"120","author":"L Agnelli","year":"2012","unstructured":"Agnelli, L. et al. Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma. Blood 120, 1274\u20131281 (2012).","journal-title":"Blood"},{"key":"24037_CR16","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1182\/blood-2012-03-419937","volume":"120","author":"G Vasmatzis","year":"2012","unstructured":"Vasmatzis, G. et al. Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas. Blood 120, 2280\u20132289 (2012).","journal-title":"Blood"},{"key":"24037_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10355","volume":"7","author":"M Feracci","year":"2016","unstructured":"Feracci, M. et al. Structural basis of RNA recognition and dimerization by the STAR proteins T-STAR and Sam68. Nat. Commun. 7, 10355 (2016).","journal-title":"Nat. Commun."},{"key":"24037_CR18","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1038\/s41590-019-0514-y","volume":"20","author":"X Li","year":"2019","unstructured":"Li, X., Bechara, R., Zhao, J., McGeachy, M. J. & Gaffen, S. L. IL-17 receptor-based signaling and implications for disease. Nat. Immunol. 20, 1594\u20131602 (2019).","journal-title":"Nat. Immunol."},{"key":"24037_CR19","doi-asserted-by":"publisher","first-page":"16701","DOI":"10.1016\/S0021-9258(19)89447-4","volume":"269","author":"L Alland","year":"1994","unstructured":"Alland, L., Peseckis, S. M., Atherton, R. E., Berthiaume, L. & Resh, M. D. Dual myristylation and palmitylation of Src family member p59fyn affects subcellular localization. J. Biol. Chem. 269, 16701\u201316705 (1994).","journal-title":"J. Biol. Chem."},{"key":"24037_CR20","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nri1944","volume":"6","author":"DJ Rawlings","year":"2006","unstructured":"Rawlings, D. J., Sommer, K. & Moreno-Garcia, M. E. The CARMA1 signalosome links the signalling machinery of adaptive and innate immunity in lymphocytes. Nat. Rev. Immunol. 6, 799\u2013812 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"24037_CR21","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00239-011-9450-7","volume":"72","author":"G Ryzhakov","year":"2011","unstructured":"Ryzhakov, G., Blazek, K. & Udalova, I. A. Evolution of vertebrate immunity: sequence and functional analysis of the SEFIR domain family member Act1. J. Mol. Evol. 72, 521\u2013530 (2011).","journal-title":"J. Mol. Evol."},{"key":"24037_CR22","first-page":"ra63","volume":"2","author":"C Liu","year":"2009","unstructured":"Liu, C. et al. Act1, a U-box E3 ubiquitin ligase for IL-17 signaling. Sci. Signal 2, ra63 (2009).","journal-title":"Sci. Signal"},{"key":"24037_CR23","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41590-020-0706-5","volume":"21","author":"J Choi","year":"2020","unstructured":"Choi, J. et al. Bcl-6 is the nexus transcription factor of T follicular helper cells via repressor-of-repressor circuits. Nat. Immunol. 21, 777\u2013789 (2020).","journal-title":"Nat. Immunol."},{"key":"24037_CR24","doi-asserted-by":"publisher","first-page":"7722","DOI":"10.1038\/sj.onc.1204868","volume":"20","author":"GD Bren","year":"2001","unstructured":"Bren, G. D. et al. Transcription of the RelB gene is regulated by NF-kappaB. Oncogene 20, 7722\u20137733 (2001).","journal-title":"Oncogene"},{"key":"24037_CR25","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/ni.1867","volume":"11","author":"HC Chang","year":"2010","unstructured":"Chang, H. C. et al. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat. Immunol. 11, 527\u2013534 (2010).","journal-title":"Nat. Immunol."},{"key":"24037_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrd2781","volume":"8","author":"V Baud","year":"2009","unstructured":"Baud, V. & Karin, M. Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat. Rev. Drug Disco. 8, 33\u201340 (2009).","journal-title":"Nat. Rev. Drug Disco."},{"key":"24037_CR27","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1002\/j.1460-2075.1993.tb05812.x","volume":"12","author":"SD Levin","year":"1993","unstructured":"Levin, S. D., Anderson, S. J., Forbush, K. A. & Perlmutter, R. M. A dominant-negative transgene defines a role for p56lck in thymopoiesis. EMBO J. 12, 1671\u20131680 (1993).","journal-title":"EMBO J."},{"key":"24037_CR28","doi-asserted-by":"publisher","first-page":"5827","DOI":"10.1182\/blood-2010-10-312603","volume":"117","author":"RL Piekarz","year":"2011","unstructured":"Piekarz, R. L. et al. Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma. Blood 117, 5827\u20135834 (2011).","journal-title":"Blood"},{"key":"24037_CR29","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1038\/sj.leu.2403960","volume":"19","author":"B Martinez-Delgado","year":"2005","unstructured":"Martinez-Delgado, B. et al. Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas. Leukemia 19, 2254\u20132263 (2005).","journal-title":"Leukemia"},{"key":"24037_CR30","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1158\/1078-0432.CCR-12-3151","volume":"19","author":"L Odqvist","year":"2013","unstructured":"Odqvist, L. et al. NIK controls classical and alternative NF-kappaB activation and is necessary for the survival of human T-cell lymphoma cells. Clin. Cancer Res. 19, 2319\u20132330 (2013).","journal-title":"Clin. Cancer Res."},{"key":"24037_CR31","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/ng.3415","volume":"47","author":"K Kataoka","year":"2015","unstructured":"Kataoka, K. et al. Integrated molecular analysis of adult T cell leukemia\/lymphoma. Nat. Genet 47, 1304\u20131315 (2015).","journal-title":"Nat. Genet"},{"key":"24037_CR32","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1182\/blood.2019002639","volume":"135","author":"RWJ Wong","year":"2020","unstructured":"Wong, R. W. J. et al. Feed-forward regulatory loop driven by IRF4 and NF-kappaB in adult T-cell leukemia\/lymphoma. Blood 135, 934\u2013947 (2020).","journal-title":"Blood"},{"key":"24037_CR33","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1182\/blood-2014-05-578575","volume":"125","author":"RL Boddicker","year":"2015","unstructured":"Boddicker, R. L. et al. The oncogenic transcription factor IRF4 is regulated by a novel CD30\/NF-kappaB positive feedback loop in peripheral T-cell lymphoma. Blood 125, 3118\u20133127 (2015).","journal-title":"Blood"},{"key":"24037_CR34","doi-asserted-by":"publisher","unstructured":"Wang, H. et al. A novel model of alternative NF-\u03baB pathway activation in anaplastic large cell lymphoma. Leukemia https:\/\/doi.org\/10.1038\/s41375-020-01088-y, Epub ahead of print (2020).","DOI":"10.1038\/s41375-020-01088-y"},{"key":"24037_CR35","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ccell.2019.07.008","volume":"36","author":"L Mondragon","year":"2019","unstructured":"Mondragon, L. et al. GAPDH overexpression in the T cell lineage promotes angioimmunoblastic T cell lymphoma through an NF-kappaB-dependent mechanism. Cancer Cell 36, 268\u2013287 (2019). e10.","journal-title":"Cancer Cell"},{"key":"24037_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06354-3","volume":"9","author":"SE Arthur","year":"2018","unstructured":"Arthur, S. E. et al. Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma. Nat. Commun. 9, 4001 (2018).","journal-title":"Nat. Commun."},{"key":"24037_CR37","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1182\/blood-2008-07-170183","volume":"113","author":"S Bea","year":"2009","unstructured":"Bea, S. et al. Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling. Blood 113, 3059\u20133069 (2009).","journal-title":"Blood"},{"key":"24037_CR38","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1182\/blood.2019001880","volume":"134","author":"RI Panea","year":"2019","unstructured":"Panea, R. I. et al. The whole-genome landscape of Burkitt lymphoma subtypes. Blood 134, 1598\u20131607 (2019).","journal-title":"Blood"},{"key":"24037_CR39","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s43018-020-00161-w","volume":"2","author":"CS Moon","year":"2021","unstructured":"Moon, C. S. et al. FYN\u2013TRAF3IP2 induces NF-\u03baB signaling-driven peripheral T-cell lymphoma. Nat. Cancer 2, 98\u2013113 (2021).","journal-title":"Nat. Cancer"},{"key":"24037_CR40","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.1128\/MCB.12.12.5438","volume":"12","author":"LK Timson Gauen","year":"1992","unstructured":"Timson Gauen, L. K., Kong, A. N., Samelson, L. E. & Shaw, A. S. p59fyn tyrosine kinase associates with multiple T-cell receptor subunits through its unique amino-terminal domain. Mol. Cell Biol. 12, 5438\u20135446 (1992).","journal-title":"Mol. Cell Biol."},{"key":"24037_CR41","doi-asserted-by":"publisher","first-page":"ra73","DOI":"10.1126\/scisignal.2001653","volume":"4","author":"P Shi","year":"2011","unstructured":"Shi, P. et al. Persistent stimulation with interleukin-17 desensitizes cells through SCFbeta-TrCP-mediated degradation of Act1. Sci. Signal 4, ra73 (2011).","journal-title":"Sci. Signal"},{"key":"24037_CR42","doi-asserted-by":"crossref","unstructured":"Prescott, J. A. & Cook, S. J. Targeting IKKbeta in cancer: challenges and opportunities for the therapeutic utilisation of IKKbeta inhibitors. Cells 7, 115(2018).","DOI":"10.3390\/cells7090115"},{"key":"24037_CR43","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","volume":"20","author":"R Singh","year":"2019","unstructured":"Singh, R., Letai, A. & Sarosiek, K. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat. Rev. Mol. Cell Biol. 20, 175\u2013193 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"24037_CR44","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13045-020-00995-y","volume":"13","author":"S Venugopal","year":"2020","unstructured":"Venugopal, S. & Mascarenhas, J. Novel therapeutics in myeloproliferative neoplasms. J. Hematol. Oncol. 13, 162 (2020).","journal-title":"J. Hematol. Oncol."},{"key":"24037_CR45","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1038\/s41591-019-0668-z","volume":"25","author":"S Khan","year":"2019","unstructured":"Khan, S. et al. A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity. Nat. Med 25, 1938\u20131947 (2019).","journal-title":"Nat. Med"},{"key":"24037_CR46","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41577-018-0020-8","volume":"18","author":"G Gaud","year":"2018","unstructured":"Gaud, G., Lesourne, R. & Love, P. E. Regulatory mechanisms in T cell receptor signalling. Nat. Rev. Immunol. 18, 485\u2013497 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"24037_CR47","first-page":"1455","volume":"5","author":"A Veillette","year":"1990","unstructured":"Veillette, A. & Fournel, M. The CD4 associated tyrosine protein kinase p56lck is positively regulated through its site of autophosphorylation. Oncogene 5, 1455\u20131462 (1990).","journal-title":"Oncogene"},{"key":"24037_CR48","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.3324\/haematol.2009.007328","volume":"94","author":"E Lierman","year":"2009","unstructured":"Lierman, E., Van Miegroet, H., Beullens, E. & Cools, J. Identification of protein tyrosine kinases with oncogenic potential using a retroviral insertion mutagenesis screen. Haematologica 94, 1440\u20131444 (2009).","journal-title":"Haematologica"},{"key":"24037_CR49","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/bjh.15702","volume":"184","author":"JM Umakanthan","year":"2019","unstructured":"Umakanthan, J. M. et al. Phase I\/II study of dasatinib and exploratory genomic analysis in relapsed or refractory non-Hodgkin lymphoma. Br. J. Haematol. 184, 744\u2013752 (2019).","journal-title":"Br. J. Haematol."},{"key":"24037_CR50","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1158\/0008-5472.CAN-19-2787","volume":"80","author":"TB Nguyen","year":"2020","unstructured":"Nguyen, T. B. et al. Dasatinib is an effective treatment for angioimmunoblastic T-cell lymphoma. Cancer Res. 80, 1875\u20131884 (2020).","journal-title":"Cancer Res."},{"key":"24037_CR51","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhlen","year":"2015","unstructured":"Uhlen, M. et al. Proteomics. Tissue-based map of the human proteome. Science 347, 1260419 (2015).","journal-title":"Science"},{"key":"24037_CR52","doi-asserted-by":"crossref","unstructured":"Nicorici, D. et al. FusionCatcher \u2013 a tool for finding somatic fusion genes in paired-end RNA-sequencing data. Preprint at https:\/\/www.biorxiv.org\/content\/10.1101\/011650v1 (2014).","DOI":"10.1101\/011650"},{"key":"24037_CR53","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim, D., Paggi, J. M., Park, C., Bennett, C. & Salzberg, S. L. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 37, 907\u2013915 (2019).","journal-title":"Nat. Biotechnol."},{"key":"24037_CR54","doi-asserted-by":"crossref","unstructured":"Danecek, P. et al. Twelve years of SAMtools and BCFtools. Gigascience 10, giab008(2021).","DOI":"10.1093\/gigascience\/giab008"},{"key":"24037_CR55","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166\u2013169 (2015).","journal-title":"Bioinformatics"},{"key":"24037_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"24037_CR57","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"24037_CR58","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1093\/nar\/gks543","volume":"40","author":"C Herrmann","year":"2012","unstructured":"Herrmann, C., Van de Sande, B., Potier, D. & Aerts, S. i-cisTarget: an integrative genomics method for the prediction of regulatory features and cis-regulatory modules. Nucleic Acids Res. 40, e114 (2012).","journal-title":"Nucleic Acids Res."},{"key":"24037_CR59","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-1-59745-409-4_7","volume":"506","author":"J Lee","year":"2009","unstructured":"Lee, J., Sadelain, M. & Brentjens, R. Retroviral transduction of murine primary T lymphocytes. Methods Mol. Biol. 506, 83\u201396 (2009).","journal-title":"Methods Mol. Biol."},{"key":"24037_CR60","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/PAI.0000000000000203","volume":"24","author":"CR Scalia","year":"2016","unstructured":"Scalia, C. R., Gendusa, R. & Cattoretti, G. A 2-step laemmli and antigen retrieval method improves immunodetection. Appl Immunohistochem. Mol. Morphol. 24, 436\u2013446 (2016).","journal-title":"Appl Immunohistochem. Mol. Morphol."},{"key":"24037_CR61","doi-asserted-by":"publisher","first-page":"e2005970","DOI":"10.1371\/journal.pbio.2005970","volume":"16","author":"C McQuin","year":"2018","unstructured":"McQuin, C. et al. CellProfiler 3.0: next-generation image processing for biology. PLoS Biol. 16, e2005970 (2018).","journal-title":"PLoS Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-24037-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-24037-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-24037-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T20:37:03Z","timestamp":1699130223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-24037-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,17]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["24037"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-24037-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-200114\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,17]]},"assertion":[{"value":"3 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.D. holds a chair funded by Roche. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3705"}}